Publications

5808 Results

Funding patient-reported outcomes in cancer clinical trials

Authors
CM Moinpour;AM Denicoff;DW Bruner;AB Kornblith;SR Land;A O'Mara;E Trimble
Journal / Conference
Journal of Clinical Oncology 25(32):5100-5105
Year
2007
Research Committee(s)
Cancer Control
PMID
PMID17991928

Correlation of RTOG 9704 (adjuvant therapy (rx) of pancreatic adenocarcinoma (pan ca)) radiation therapy quality assurance scores (RTQASc) with survival (S)

Authors
RA Abrams;KA Winter;WF Regine;H Safran;JP Hoffman;AA Konski;AB Benson;JS Macdonald;TA Rich;CG Willett
Journal / Conference
Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#4523
Year
2007
Research Committee(s)
Gastrointestinal
Study Number(s)
R9704

Gene expression levels of HER2 and IL-8 and polymorphism in IL-8 associated with clinical outcome in advanced or metastatic gastric cancer treated with lapatinib in SWOG 0413 trial

Authors
H Chang;M Azuma;B Goldman;F Nagashima;S Iqbal;K Danenberg;J Benedetti;W Zhang;C Blanke;H Lenz
Journal / Conference
Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#4647
Year
2007
Research Committee(s)
Gastrointestinal
Study Number(s)
S0413

S9900: surgery alone or surgery plus induction (ind) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): follow-up on a phase III trial

Authors
K Pisters;E Vallieres;PA Bunn;J Crowley;K Chansky;R Ginsberg;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#7520
Year
2007
Research Committee(s)
Lung
Study Number(s)
S9900

Effect of consolidation with arsenic trioxide (As2O3) on event-free survival (EFS) and overall survival (OS) among patients with newly diagnosed acute promyelocytic leukemia (APL): North American Intergroup Protocol C9710

Authors
BL Powell;B Moser;W Stock;RE Gallagher;C Willman;S Coutre;JH Feusner;FR Appelbaum;MS Tallman;RA Larson
Journal / Conference
Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#2
Year
2007
Research Committee(s)
Leukemia
Study Number(s)
C9710

Prognostic significance of initial clinical and molecular genetic features of acute promyelocytic leukemia (APL): Results from the North American Intergroup Trial, C9710

Authors
W Stock;B Moser;BL Powell;FR Appelbaum;MS Tallman;RA Larson;JH Feusner;CD Bloomfield;C Willman;RE Gallagher
Journal / Conference
Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#7016
Year
2007
Research Committee(s)
Leukemia
Study Number(s)
C9710

Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis [PMID17023574; PMC1794073]

Authors
F Zhan;B Barlogie;V Arzoumanian;Y Huang;DR Williams;K Hollmig;M Pineda-Roman;G Tricot;F van Rhee;M Zangari;M Dhodapkar;JD Shaughnessy, Jr
Journal / Conference
Blood 109(4):1692-1700
Year
2007
Research Committee(s)
Myeloma
Study Number(s)
S0120

Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy [PMID17389240; PMC2118551]

Authors
R Spisek;A Kukreja;LC Chen;P Matthews;A Mazumder;D Vesole;S Jagannath;HA Zebroski;AJG Simpson;G Ritter;B Durie;J Crowley;JD Shaughnessy Jr;MJ Scanlan;AO Gure;B Barlogie;MV Dhodapkar
Journal / Conference
Journal of Experimental Medicine 204(4):831-840
Year
2007
Research Committee(s)
Myeloma
Study Number(s)
S0120

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival [PMID17299095; PMC1885523]

Authors
A Wiestner;M Tehrani;M Chiorazzi;G Wright;F Gibellini;K Nakayama;H Liu;A Rosenwald;HK Muller-Hermelink;G Ott;WC Chan;TC Greiner;DD Weisenburger;J Vose;JO Armitage;RD Gascoyne;JM Connors;E Campo;E Montserrat;F Bosch;EB Smeland;S Kvaloy;H Holte;J Delabie;RI Fisher;TM Grogan;TP Miller;WH Wilson;EJ Jaffe;LM Staudt
Journal / Conference
Blood 109(11):4599-4606
Year
2007
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Revised response criteria for malignant lymphoma

Authors
BD Cheson;B Pfistner;ME Juweid;RD Gascoyne;L Specht;SJ Horning;B Coiffier;RI Fisher;A Hagenbeck;E Zucca;ST Rosen;S Stroobants;TA Lister;RT Hoppe;M Dreyling;K Tobinai;JM Vose;JM Connors;M Federico;V Diehl
Journal / Conference
Journal of Clinical Oncology 25(5):579-586
Year
2007
Research Committee(s)
Lymphoma
PMID
PMID17242396